Willow Biosciences Inc (WLLW) — Cash Flow Reinvestment Rate

Latest as of March 2019: 2.89x

Willow Biosciences Inc (WLLW) has a Cash Flow Reinvestment Rate of 2.89x as of March 2019, reinvesting CA$29.33K (capex CA$14.67K plus investments CA$-14.67K) from operating cash flow of CA$10.14K. Check WLLW cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

2.89x
(Capex + Investments) / Operating CF

Total Reinvested

CA$29.33K
Capex + Investments

Operating Cash Flow

CA$10.14K
CAD

Capital Expenditures

CA$14.67K
CAD

Willow Biosciences Inc Cash Flow Reinvestment Rate (2001–2001)

Historical reinvestment intensity for Willow Biosciences Inc across 1 annual periods. Explore long-term investment intensity of Willow Biosciences Inc to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Willow Biosciences Inc (2001–2001)

Year-by-year capital reinvestment analysis for Willow Biosciences Inc. For live market cap and broader valuation context, see WLLW market cap overview.

Year Reinvestment Rate Total Reinvested (CAD) Operating CF Capex YoY Change
2001 0.00x CA$0.00 CA$281.00 CA$0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow